These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23479455)

  • 1. The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats.
    Nikiforuk A; Fijał K; Potasiewicz A; Popik P; Kos T
    J Psychopharmacol; 2013 May; 27(5):469-76. PubMed ID: 23479455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity.
    Gravius A; Laszy J; Pietraszek M; Sághy K; Nagel J; Chambon C; Wegener N; Valastro B; Danysz W; Gyertyán I
    Behav Pharmacol; 2011 Apr; 22(2):122-35. PubMed ID: 21301322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats.
    Nikiforuk A; Gołembiowska K; Popik P
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):37-48. PubMed ID: 19729284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
    Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats.
    Nikiforuk A; Popik P
    Psychopharmacology (Berl); 2012 Mar; 220(1):65-74. PubMed ID: 21918808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.
    Nikiforuk A; Hołuj M; Kos T; Popik P
    Neuropharmacology; 2016 Jun; 105():351-360. PubMed ID: 26826431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics.
    Rodefer JS; Nguyen TN; Karlsson JJ; Arnt J
    Neuropsychopharmacology; 2008 Oct; 33(11):2657-66. PubMed ID: 18094666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia.
    Nikiforuk A
    Rev Neurosci; 2014; 25(3):367-82. PubMed ID: 24501158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats.
    Nikiforuk A; Kos T; Fijał K; Hołuj M; Rafa D; Popik P
    PLoS One; 2013; 8(6):e66695. PubMed ID: 23776692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.
    Potasiewicz A; Hołuj M; Kos T; Popik P; Arias HR; Nikiforuk A
    Neuropharmacology; 2017 Feb; 113(Pt A):188-197. PubMed ID: 27717880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.
    Nikiforuk A; Kos T; Hołuj M; Potasiewicz A; Popik P
    Neuropharmacology; 2016 Feb; 101():389-400. PubMed ID: 26232639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics.
    Cilia J; Hatcher P; Reavill C; Jones DN
    J Psychopharmacol; 2007 May; 21(3):302-11. PubMed ID: 17591657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain.
    Borsini F; Bordi F; Poggi A; Di Matteo V
    J Psychopharmacol; 2015 Jul; 29(7):802-11. PubMed ID: 25735994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration.
    Nikiforuk A; Kos T; Wesołowska A
    Psychopharmacology (Berl); 2011 Oct; 217(3):411-8. PubMed ID: 21499701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.
    Schechter LE; Lin Q; Smith DL; Zhang G; Shan Q; Platt B; Brandt MR; Dawson LA; Cole D; Bernotas R; Robichaud A; Rosenzweig-Lipson S; Beyer CE
    Neuropsychopharmacology; 2008 May; 33(6):1323-35. PubMed ID: 17625499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Szewczyk B; Sowa-Kućma M; Wasik A; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1079-88. PubMed ID: 26077660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats.
    de Bruin NM; van Drimmelen M; Kops M; van Elk J; Wetering MM; Schwienbacher I
    Behav Brain Res; 2013 May; 244():15-28. PubMed ID: 23384714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of clozapine on ketamine-induced deficits in attentional set shift task in mice.
    Szlachta M; Pabian P; Kuśmider M; Solich J; Kolasa M; Żurawek D; Dziedzicka-Wasylewska M; Faron-Górecka A
    Psychopharmacology (Berl); 2017 Jul; 234(14):2103-2112. PubMed ID: 28405711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats.
    Jones KM; McDonald IM; Bourin C; Olson RE; Bristow LJ; Easton A
    Psychopharmacology (Berl); 2014 Feb; 231(4):673-83. PubMed ID: 24057763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats.
    Popik P; Holuj M; Nikiforuk A; Kos T; Trullas R; Skolnick P
    Psychopharmacology (Berl); 2015 Mar; 232(6):1025-38. PubMed ID: 25260339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.